Determination of zafirlukast, a selective leukotriene antagonist, human plasma by normal-phase high-performance liquid chromatography with fluorescence detection

Journal of Chromatography B: Biomedical Applications

Volumn 696, Issue 1, 1997, Pages 131-136

  Bui, Khanh H ^a   Kennedy, Coleen M ^a,b   Azumaya, Connie T ^a   Birmingham, Bruce K ^a  

^a ASTRAZENECA   (United Kingdom)

^b DUPONT COMPANY   (United States)

Author keywords

Zafirlukast

Indexed keywords

LEUKOTRIENE RECEPTOR BLOCKING AGENT; ZAFIRLUKAST;

ARTICLE; DRUG DETERMINATION; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; PLASMA; PRIORITY JOURNAL; SOLID PHASE EXTRACTION;

ADMINISTRATION, ORAL; ANTI-ASTHMATIC AGENTS; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CIRCADIAN RHYTHM; HUMANS; LEUKOTRIENE ANTAGONISTS; LINEAR MODELS; OSMOLAR CONCENTRATION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, FLUORESCENCE; TIME FACTORS; TOSYL COMPOUNDS;

EID: 0030794657     PISSN: 15726495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4347(97)00092-3     Document Type: Article

References (7)

1. S.B. French and K.H. Bui, ZENECA Pharmaceuticals, unpublished results.
2. D.J. Popovich, J.B. Dixon and B.J. Ehrlich, J. Chromatogr. Sci., 17 (1979) 643.
3. W.A. McKinley, Abstracts, Pittsburgh Conference, March 1981, Abstract No. 449.
4. A.D. Skoog and D.N. West, Principles of Instrumental Analysis, Saunders College, Philadelphia, PA, 2nd ed., 1980, p. 286.
5. M.J. Sepaniak and C.N. Kettler, in E.S. Yeung (Editor), Detectors for Liquid Chromatography, Wiley, New York, 1986, p. 155.
6. E.L. Wehry, in G.G. Guilbault (Editor), Practical Fluorescence, Marcel Dekker, New York, 1990, pp. 145-146.
7. J.R. Lang and S. Bolston, J. Pharm. Biomed. Anal., 9 (1991) 435.